8-K filings and company releases

Company news

1 article on Beam Therapeutics.

Articles GetSignal writes with AI from a company's own 8-K filing or press release, newest first. Each one links to the filing or release it was written from.Articles GetSignal writes with AI from a company's own 8-K filing or press release, newest first.

Download on the App StoreGet it on Google Play

Free on iOS and Android

BEAM articles

Newest first, 25 to a page
  1. Nov 10, 2026 · Company release

    Risto-cel meets primary endpoint of at least 12 months free of severe VOCs

    Beam Therapeutics also said the study met all secondary endpoints and expects to submit a U.S. biologics license application as early as year-end 2026.

    Company release

How these are written

  • The source: the company's own 8-K filing or press release, linked from every article. What the company says is attributed to the company.
  • The checks: each article is written by GetSignal with AI and checked against its source before it is shown.
  • The date: the day the company filed the 8-K or published the release.
  • Not investment advice. An article reports what the company disclosed; it is not a view on the stock.